These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 13392574)

  • 21. Visceral leishmaniasis (kala-azar) and pregnancy.
    Figueiró-Filho EA; Duarte G; El-Beitune P; Quintana SM; Maia TL
    Infect Dis Obstet Gynecol; 2004; 12(1):31-40. PubMed ID: 15460194
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [LEISHMANIASIS AS ENCOUNTERED IN FRANCE. CLINICAL AND THERAPEUTIC ASPECTS].
    SCHNEIDER J
    Rev Prat; 1964 Mar; 14():1149-63. PubMed ID: 14146424
    [No Abstract]   [Full Text] [Related]  

  • 23. Treatment of visceral leishmaniasis.
    Ozsoylu S
    Pediatr Hematol Oncol; 2006; 23(5):449-51; author reply 455-7. PubMed ID: 16728366
    [No Abstract]   [Full Text] [Related]  

  • 24. [IMPORTANCE OF LYMPH NODE BIOPSY IN THE DIAGNOSIS OF KALA-AZAR IN THE ADULT].
    MEMIN Y; PERNOD J; LARRIBAUD J
    Bull Mem Soc Med Hop Paris; 1963 May; 114():759-66. PubMed ID: 14054214
    [No Abstract]   [Full Text] [Related]  

  • 25. Post-kala-azar dermal leishmaniasis with visceral leishmaniasis: a rare presentation.
    Rijal A; Agrawal S; Agarwalla A; Agrawal A; Rijal S
    Int J Dermatol; 2005 Jun; 44(6):494-6. PubMed ID: 15941439
    [No Abstract]   [Full Text] [Related]  

  • 26. Drug regimens for visceral leishmaniasis in Mediterranean countries.
    Gradoni L; Soteriadou K; Louzir H; Dakkak A; Toz SO; Jaffe C; Dedet JP; Campino L; Cañavate C; Dujardin JC
    Trop Med Int Health; 2008 Oct; 13(10):1272-6. PubMed ID: 18764817
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antimony-induced cerebellar ataxia.
    Khalil EA; Ahmed AE; Musa AM; Hussein MH
    Saudi Med J; 2006 Jan; 27(1):90-2. PubMed ID: 16432602
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [8 cases of kala-azar cured with glucantime].
    SALA GINABREDA JM; PI FERRER A; WOESSNER CASAS S
    Acta Pediatr Esp; 1962 Jun; 20():299-305. PubMed ID: 13991000
    [No Abstract]   [Full Text] [Related]  

  • 29. Some compounds active against experimental visceral leishmaniasis.
    CAPPUCCINO EF; STAUBER LA
    Proc Soc Exp Biol Med; 1959; 101():742-4. PubMed ID: 13807568
    [No Abstract]   [Full Text] [Related]  

  • 30. Visceral leishmaniasis, or kala azar (KA): high incidence of refractoriness to antimony is contributed by anthroponotic transmission via post-KA dermal leishmaniasis.
    Singh R; Kumar D; Ramesh V; Negi NS; Singh S; Salotra P
    J Infect Dis; 2006 Aug; 194(3):302-6. PubMed ID: 16826477
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disseminated cutaneous leishmaniasis after visceral disease in a patient with AIDS.
    Calza L; D'Antuono A; Marinacci G; Manfredi R; Colangeli V; Passarini B; Orioli R; Varoli O; Chiodo F
    J Am Acad Dermatol; 2004 Mar; 50(3):461-5. PubMed ID: 14988693
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Liver transplant recipient with concomitant cutaneous and visceral leishmaniasis.
    Ozcan D; Seçkin D; Allahverdiyev AM; Weina PJ; Aydin H; Ozçay F; Haberal M
    Pediatr Transplant; 2007 Mar; 11(2):228-32. PubMed ID: 17300508
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A case report on self-cure of visceral leishmaniasis.
    Das VN; Dinesh DS; Verma N; Kar SK
    J Commun Dis; 2002 Dec; 34(4):302-3. PubMed ID: 14710862
    [No Abstract]   [Full Text] [Related]  

  • 34. [Effectiveness of therapy inducing contraction of spleen in a rare case of visceral leishmaniasis in adult].
    MAJANI A
    Rass Clin Ter; 1953; 52(4):241-6. PubMed ID: 13145776
    [No Abstract]   [Full Text] [Related]  

  • 35. Possibility of membrane modification as a mechanism of antimony resistance in Leishmania donovani.
    Kothari H; Kumar P; Sundar S; Singh N
    Parasitol Int; 2007 Mar; 56(1):77-80. PubMed ID: 17169604
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The current status of the problem of visceral leishmaniasis].
    MIRZOIAN NA
    Med Zh Uzb; 1961 Aug; 8():54-9. PubMed ID: 14474513
    [No Abstract]   [Full Text] [Related]  

  • 37. Leishmania donovani vs immunity: T-cells sensitized from Leishmania of one donor may modulate their cytokines pattern on re-stimulation with Leishmania from different donor in visceral leishmaniasis.
    Narayan S; Bimal S; Singh SK; Gupta AK; Singh VP; Sinha PK; Das P
    Exp Parasitol; 2009 Jan; 121(1):69-75. PubMed ID: 18948098
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Kalaazar and cortancyl].
    Cosset J; Amiel JL
    Alger Medicale; 1958 Jun; 62(6):665-7. PubMed ID: 13571110
    [No Abstract]   [Full Text] [Related]  

  • 39. Characterization of natural antimony resistance in Leishmania donovani isolates.
    Mittal MK; Rai S; Ashutosh ; Ravinder ; Gupta S; Sundar S; Goyal N
    Am J Trop Med Hyg; 2007 Apr; 76(4):681-8. PubMed ID: 17426170
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antimony-based antileishmanial compounds prolong the cardiac action potential by an increase in cardiac calcium currents.
    Kuryshev YA; Wang L; Wible BA; Wan X; Ficker E
    Mol Pharmacol; 2006 Apr; 69(4):1216-25. PubMed ID: 16418337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.